Epstein Barr virus in relation to apoptosis markers and patients' outcome in pediatric B-cell Non-Hodgkin lymphoma

Cancer Letters

Volumn 307, Issue 2, 2011, Pages 221-226

  Chabay, P ^a   Lara, J ^a   Lorenzetti, M ^a   Cambra, P ^a   Acosta Haab, G ^a   Aversa, L ^a   De Matteo, E ^a   Preciado, M V ^a  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

Apoptosis; Epstein Barr virus; Pediatric B cell Non Hodgkin lymphoma

Indexed keywords

BIOLOGICAL MARKER; CASPASE 3; KI 67 ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; VIRUS RNA;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; EVENT FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MALE; NONHODGKIN LYMPHOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VIRUS EXPRESSION;

CHILD; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOMA, B-CELL; MALE; TREATMENT OUTCOME;

HUMAN HERPESVIRUS 4;

EID: 79957648413     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.04.006     Document Type: Article

References (40)

1. Oschlies I., Klapper W., Zimmermann M., et al. Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster). Multicenter Trial. Blood 2006, 107(10):4047-4052.
2. Burkhardt B., Zimmermann M., Oschlies I., et al. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br. J. Haematol. 2005, 131(1):39-49.
3. Registro Oncopediátrico Argentino. Resultados, 2000-2008. (accessed 17.01.11). http://www.roha.org.ar.
4. Macsween K., Crawford D. Epstein Barr virus-recent advances. Lancet Infect. Dis. 2003, 3(3):131-140.
5. Young L., Rickinson A. Esptein Barr virus: 40 years on. Nat. Rev. Cancer 2004, 4(10):757-768.
6. Young L.S., Murray P.G. Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 2003, 22(33):5108-5121.
7. Küppers R. B cells under influence. transformation of B cells by Epstein-Barr virus. Nat. Rev. Immunol. 2003, 3(10):801-812.
8. Li H., Chang Y. Epstein-Barr virus latent membrane protein 1: structure and functions. J. Biomed. Sci. 2003, 10(5):490-504.
9. Danial N.N., Korsmeyer S.J. Cell death: critical control points. Cell 2004, 116(2):205-219.
10. Rowe M., Peng-Pilon M., Huen D.S., et al. Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-B activation and to induction of cell surface markers. J. Virol. 1994, 68(9):5602-5612.
11. Grimm T., Schneider S., Naschberger E., et al. EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX. Blood 2005, 105(8):3263-3269.
12. Thorley-Lawson D.A., Allday M.J. The curious case of the tumour virus: 50 years of Burkitt's lymphoma. Nat. Rev. Microbiol. 2008, 6(12):913-924.
13. Igney F.H., Krammer P.H. Death and anti-death: tumour resistance to apoptosis. Nat. Rev. Cancer 2002, 2(4):277-288.
14. Berglund M., Thunberg U., Amini R.M., et al. Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis. Mod. Pathol. 2005, 18(8):1113-1120.
15. Gascoyne R.D., Krajewska M., Krajewski S., Connors J.M., Reed J.C. Prognostic significance of Bax protein expression in diffuse aggressive non-Hodgkin's lymphoma. Blood 1997, 90(8):3173-3178.
16. Miles R.R., Raphael M., McCarthy K., et al. Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: Report of the French-American-British (FAB) international study group. Pediatr. Blood Cancer 2008, 51(3):369-374.
17. Muris J.J., Cillessen S.A., Vos W., et al. Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas. Blood 2005, 105(7):2916-2923.
18. ten Berge R.L., Meijer C.J., Dukers D.F., et al. Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma. Blood 2002, 99(12):4540-4546.
19. Park S., Lee J., Ko Y.H., et al. The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood 2007, 110(3):972-978.
20. Aktaş S., Kargi{dotless} A., Olgun N., Diniz G., Erbay A., Vergin C. Prognostic significance of cell proliferation and apoptosis-regulating proteins in Epstein-Barr virus positive and negative pediatric non-Hodgkin's lymphoma. Pathol. Oncol. Res. 2009, 15(3):345-350.
21. Dupuis J., Emile J.F., Mounier N., et al. Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: a Groupe d'Etude des Lymphomes de l'Adulte (GELA) study. Blood 2006, 108(13):4163-4169.
22. Kawano R., Ohshima K., Wakamatsu S., Suzumiya J., Kikuchi M., Tamura K. Epstein-Barr virus genome level, T-cell clonality and the prognosis of angioimmunoblastic T-cell lymphoma. Haematologica 2005, 90(9):1192-1196.
23. Labrecque L.G., Xue S.A., Kazembe P., et al. Expression of Epstein-Barr virus lytically related genes in African Burkitt's lymphoma: correlation with patient response to therapy. Int. J. Cancer 1999, 81(1):6-11.
24. Bairey O., Zimra Y., Shaklai M., Okon E., Rabizadeh E. Bcl-2, Bcl-X, Bax, and Bak expression in short- and long-lived patients with diffuse large B-cell lymphomas. Clin. Cancer Res. 1999, 5(10):2860-2866.
25. Swerdlow S.H., Campo E., Harris N.L., et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, IARC Press, Lyon, France. fourth ed.
26. Frost M., Newell J., Lones M., Tripp S., Cairo M., Perkins S. Comparative immunohistochemical analysis of pediatric Burkitt lymphoma and diffuse large B-cell lymphoma. Am. J. Clin. Pathol. 2004, 121(3):384-392.
27. Chabay P., Burna V., Moar A., et al. Prevalencia de la infeccion por el virus de Epstein Barr en pacientes pediatricos. Rev. Hosp. Ninos. B Aires 1999, 41(7):88-91.
28. Chabay P.A., Barros M.H., Hassan R., et al. Pediatric Hodgkin lymphoma in 2 South American series: a distinctive epidemiologic pattern and lack of association of Epstein-Barr virus with clinical outcome. J. Pediatr. Hematol. Oncol. 2008, 30(4):285-291.
29. Kelly G.L., Rickinson A.B. Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy. Hematology 2007, 277-284.
30. Queiroga E.M., Gualco G., Weiss L.M., et al. Burkitt lymphoma in Brazil is characterized by geographically distinct clinicopathologic features. Am. J. Clin. Pathol. 2008, 130(6):946-956.
31. Hassan R., Klumb C.E., Felisbino F.E., et al. Clinical and demographic characteristics of Epstein-Barr virus-associated childhood Burkitt's lymphoma in Southeastern Brazil: epidemiological insights from an intermediate risk region. Haematologica 2008, 93(5):780-783.
32. Rao C.R., Gutierrez M.I., Bhatia K., et al. Association of Burkitt's lymphoma with the Epstein-Barr virus in two developing countries. Leuk. Lymphoma 2000, 39(3-4):329-337.
33. Yamauchi A., Fujita S., Ikeda J., et al. Diffuse large B-cell lymphoma in the young in Japan: a study by the Osaka Lymphoma Study Group. Am. J. Hematol. 2007, 82(10):893-897.
34. Butel J.S. Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 2000, 21(3):405-426.
35. Rowe M., Kelly G.L., Bell A.I., Rickinson A.B. Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology. Semin. Cancer Biol. 2009, 19(6):377-388.
36. Henderson S., Rowe M., Gregory C., et al. Induction of bcl2 expression by Epstein-Barr virus latent membrane protein-1 protects infected B cells from programmed cell death. Cell 1991, 65(7):1107-1115.
37. Komano J., Takada K. Role of bcl-2 in Epstein-Barr virus-induced malignant conversion of Burkitt's lymphoma cell line Akata. J. Virol. 2001, 75(3):1561-1564.
38. Wang Y., Luo B., Yan L.P., et al. Relationship between Epstein-Barr virus-encoded proteins with cell proliferation, apoptosis, and apoptosis-related proteins in gastric carcinoma. World J. Gastroenterol. 2005, 11(5):3234-3239.
39. Chuang S.S., Huang W.T., Hsieh P.P., et al. Sporadic paediatric and adult Burkitt lymphomas share similar phenotypic and genotypic features. Histopathology 2008, 52(4):427-435.
40. Fu D.X., Tanhehco Y.C., Chen J., et al. Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors. Nat. Med. 2008, 14(10):1118-1122.